Cozad Asset Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.2M | Sell |
32,071
-414
| -1% | -$208K | 1.19% | 20 |
|
|
2025
Q4 | $15.2M | Sell |
32,485
-573
| -2% | -$266K | 1.18% | 21 |
|
|
2025
Q3 | $14.1M | Buy |
33,058
+798
| +2% | +$309K | 1.12% | 24 |
|
|
2025
Q2 | $12.4M | Buy |
32,260
+2,621
| +9% | +$944K | 1.08% | 23 |
|
|
2025
Q1 | $10.2M | Sell |
29,639
-405
| -1% | -$130K | 1.02% | 27 |
|
|
2024
Q4 | $9.02M | Buy |
30,044
+126
| +0.4% | +$44K | 0.84% | 32 |
|
|
2024
Q3 | $12.2M | Sell |
29,918
-1,336
| -4% | -$489K | 1.16% | 21 |
|
|
2024
Q2 | $10M | Buy |
31,254
+5
| +0% | +$1.63K | 1% | 23 |
|
|
2024
Q1 | $10.4M | Sell |
31,249
-686
| -2% | -$210K | 1.09% | 21 |
|
|
2023
Q4 | $8.64M | Sell |
31,935
-1,309
| -4% | -$324K | 1% | 25 |
|
|
2023
Q3 | $8.18M | Buy |
33,244
+139
| +0.4% | +$38K | 1.06% | 22 |
|
|
2023
Q2 | $10M | Sell |
33,105
-1,683
| -5% | -$468K | 1.25% | 19 |
|
|
2023
Q1 | $9.17M | Sell |
34,788
-1,238
| -3% | -$314K | 1.21% | 16 |
|
|
2022
Q4 | $8.64M | Sell |
36,026
-1,568
| -4% | -$351K | 1.22% | 15 |
|
|
2022
Q3 | $6.91M | Buy |
37,594
+629
| +2% | +$125K | 1.12% | 21 |
|
|
2022
Q2 | $6.21M | Buy |
36,965
+2,451
| +7% | +$527K | 0.97% | 26 |
|
|
2022
Q1 | $8.65M | Buy |
34,514
+2,515
| +8% | +$632K | 1.21% | 17 |
|
|
2021
Q4 | $8.22M | Buy |
31,999
+5,265
| +20% | +$1.29M | 1.16% | 20 |
|
|
2021
Q3 | $6.49M | Buy |
26,734
+655
| +3% | +$160K | 1.01% | 29 |
|
|
2021
Q2 | $5.39M | Sell |
26,079
-1,274
| -5% | -$260K | 0.85% | 36 |
|
|
2021
Q1 | $5.15M | Buy |
27,353
+815
| +3% | +$144K | 0.84% | 36 |
|
|
2020
Q4 | $4.36M | Sell |
26,538
-1,475
| -5% | -$216K | 0.78% | 36 |
|
|
2020
Q3 | $3.49M | Sell |
28,013
-4,507
| -14% | -$558K | 0.66% | 39 |
|
|
2020
Q2 | $3.16M | Sell |
32,520
-638
| -2% | -$66.3K | 0.64% | 43 |
|
|
2020
Q1 | $2.98M | Buy |
33,158
+770
| +2% | +$99.7K | 1.03% | 25 |
|
|
2019
Q4 | $4.79M | Buy |
32,388
+560
| +2% | +$75.2K | 1.28% | 19 |
|
|
2019
Q3 | $3.83M | Buy |
31,828
+1,195
| +4% | +$154K | 1.11% | 23 |
|
|
2019
Q2 | $4.14M | Buy |
30,633
+585
| +2% | +$74K | 1.2% | 22 |
|
|
2019
Q1 | $3.92M | Buy |
30,048
+8,680
| +41% | +$1.17M | 1.18% | 20 |
|
|
2018
Q4 | $2.66M | Buy |
21,368
+3,375
| +19% | +$453K | 0.92% | 28 |
|
|
2018
Q3 | $2.5M | Buy |
17,993
+325
| +2% | +$40.5K | 0.73% | 37 |
|
|
2018
Q2 | $1.81M | Buy |
+17,668
| New | +$1.79M | 0.56% | 62 |
|
Other funds holding HCA
VCM
VPM
Cozad Asset Management's HCA Position: Q1 2026 in Review
Cozad Asset Management reduced its HCA Healthcare (HCA) stake by 1.3% in Q1 2026, selling an estimated $208K and leaving 32,071 shares worth $15.2M. The position accounts for 1.19% of the portfolio, ranked #20.
Cozad Asset Management first reported a position in HCA in Q2 2018 and has held it in 32 quarters since. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Cozad Asset Management held 32,071 shares of HCA Healthcare worth $15.2M as of Q1 2026.
- Cozad Asset Management sold 414 HCA Healthcare shares in Q1 2026, an estimated $208K.
- HCA Healthcare made up 1.19% of Cozad Asset Management's portfolio in Q1 2026, its #20 holding.
- Cozad Asset Management first reported a position in HCA Healthcare in Q2 2018 and has held it in 32 quarters since.
- 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Cozad Asset Management's 13F filing for Q1 2026, filed 28 May 2026.